Q3 surge in volumes sees Hapag-Lloyd sail back into calmer financial waters
Hapag-Lloyd moved into the black in the third quarter with a net profit of $56m, but sees a ...
Carriers – both air and sea – are attracted by the high yields that come with the transportation of pharmaceuticals.
Airlines have taken the highest-value shipments and are swiftly ensuring that staff and handlers are well trained. CEIV and GDP are becoming ever more important to prove that transport quality is high. And customer expectations are growing – there can be no airport “black hole”, no temperature excursions, no delays. Meanwhile, technology is becoming ever more critical – shipment visibility is key.
Maersk has introduced remote container management, which, combined with seamless transport in reefer containers, could eat into airline business. But long periods in transit, plus an insurance cap on high-value shipments will mean air is likely to remain the preferred choice for the high end.
But this Loadstar LongRead also examines what is happening in the world of shippers. Disruption has come to pharma companies too: mobile health, apps and new developments from technology companies are starting to disrupt the heavily regulated and slow-to-move pharma business. What will this mean for the logistic industry?